Brief: Spago Nanomedical Q1 Adj. EPS at SEK -0.16
09/05/2023 07:06
May 9 (Reuters) - Spago Nanomedical Q1 operating expenses SEK -17.168 million. * Q1 net income SEK -14.379 million * Q1 adjusted EPS SEK -0.16 * Q1 sales SEK 88 thousand
Recent news on Spago Nanomedical AB (publ)
See all newsBrief: Spago Nanomedical Announces Outcome Of Rights Issue
Brief: Spago Nanomedical Resolves On Rights Issue Of About SEK 16 Million
Sweden's Spago Nanomedical Q1 loss narrows
Brief: Spago Nanomedical Q1 Sales SEK 22 Thousand
Brief: Spago Nanomedical Says Tumorad-01 Study Meets Primary Endpoint Of Maximum Tolerated Dose